CST3 and hyperlipidemia: We demonstrated that deletion of apoE per se was associated with hyperlipidemia via elevations in plasma levels of both cholesterol and triglycerides; however, little consequent effect on urinary albumin excretion, plasma cystatin C levels or glomerular matrix accumulation were observed.